[1]
2019. Negligible impact of highly patient-specific decision support for potassium-increasing drug-drug interactions – a cluster-randomised controlled trial. Swiss Medical Weekly. 149, 1516 (Apr. 2019), w20035. DOI:https://doi.org/10.4414/smw.2019.20035.